In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

Medical advancements are a wonderful thing. When HIV was first discovered back in the 1980s, it was considered a death ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

In an interview with Yahoo News, Dr. Anthony Fauci discussed the state of HIV vaccine research after the recent failure of a late-stage trial funded by the National Institute of Allergy and ...

HIV has historically been extremely challenging to produce a vaccine for, in part because the virus integrates itself into the human genome rapidly—within 72 hours of transmission—thus ...

Fifteen years ago, an HIV vaccine trial conducted in Thailand and sponsored by the U.S. Army found something no other HIV vaccine trial ever had: a regimen that seemed to work.

Arguably, the Covid-19 vaccines were developed so rapidly in part because of lessons learned from HIV. Now, perhaps, lessons learned from Covid-19 will impact the development of an HIV vaccine.

HIV is a really tough foe, but if a vaccine can emerge that offers at least 50% protection against HIV infection along with being acceptably safe, 2021 could be legendary.

Work on a vaccine to halt the HIV epidemic has failed so far. But it has resulted in expertise, technology and infrastructure that is quickly pivoting toward the coronavirus.